(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on President Trump signing into law S. 2553/ S. 2554, the Know the Lowest Price Act of 2018 and the Patient Right to Know Drug Prices Act. “PCMA
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the U.S. House of Representatives’ vote on prescription drug price transparency legislation: “PBMs support increasing transparency across the entire prescription drug supply
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on S. 2554, the Patient Right to Know Drug Prices Act, scheduled to be marked up tomorrow in the U.S. Senate Committee on Health,
President Donald Trump is trying to shame the largest U.S. drugmaker for hiking prices after he earlier said industry players were planning “massive” price reductions.
If Drug Companies Had Their Way… There Would Be No Check on Their Power Download Infographic Patients Would Pay List Price for Drugs Drug companies often raise list prices annually in January and July. In January 2021, 822 brand drugs
“We support (the administration’s) call for greater flexibility in benefit design to encourage better price negotiations…” PCMA said
Sanofi and Regeneron have agreed to lower the price of their cholesterol medicine in exchange for easier access for patients covered by pharmacy benefit manager
©2024 PCMA. All Rights Reserved.
